Skip to main content

Site notifications

BeiGene AUS Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

21 result(s) found, displaying 11 to 20
  • Brukinsa (zanubrutinib) for the treatment of adult patients with mantle cell lymphoma
  • Brukinsa (zanubrutinib) for the treatment of of adult patients with Waldenström’s macroglobulinaemia
  • Australian prescription medicine decision summary
  • Australian prescription medicine decision summary

Help us improve this page